Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals

Laven, Anna; Schmitz, Katharina; Franzen, Wilhelm-Hubertus

doi:10.1007/s11096-018-0671-3

Cited by 11 publications

(11 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…24 Moreover, a German study in 2018 documented that although PV system was well-established and there were numerous reporting events in Germany, only 5-10% of serious ADRs and even lower percent of the non-serious ADRs were reported, and attributed that to the absence of mandatory continuing education programs for PV for German HCPs. 34 Practice scores showed significant improvement after education in the present work, and the number of ADRs reports increased from 2 to 13. All reported ADRs were done by pharmacists except for one that was reported by a nurse.…”

Section: Ta B L E 2 Comparison Of Kap Questionnaire Scores Of Hcps Between Groups and Within Groups In The Pre-and Post-education Phasesmentioning

confidence: 50%

Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?

et al. 2021

View full text Add to dashboard Cite

Pharmacovigilance (PV) is essential for the detection and prevention of adverse drug reactions (ADRs). According to the World Health Organization (WHO), PV is defined as ''the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem". 1 The WHO defines ADR as "a response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modifications of physiological function". 2 They are one of the leading causes of morbidity and mortality around the world resulting in increased healthcare costs. 3,4 The WHO stated that ADRs were responsible for a significant number of hospital admission ranging from 0.3% to 11%. 2 In addition, a meta-analysis has shown that ADRs were considered from the 4 th to the 6 th most common causes of death. 5 Recently, PV is of great importance as it represents a key element in the regulation of effective drug use systems in clinical practice. 6 The main goal of PV is to minimise harm caused by medications through rationalising their use, and to protect and promote

show abstract

Section: Ta B L E 2 Comparison Of Kap Questionnaire Scores Of Hcps Between Groups and Within Groups In The Pre-and Post-education Phasesmentioning

confidence: 50%

Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Many studies included in this review lacked a theoretical framework. In papers in which a theoretical framework was utilized, Inmans’ seven deadly sins for not reporting ADEs; Knowledge‐Attitude‐Practice Model (KAP); and theory of planned behaviour were the most frequently used theories to understand pharmacists' reporting of ADEs …”

Section: Resultsmentioning

confidence: 99%

“…[24,[36][37][38] Many studies included in this review lacked a theoretical framework. In papers in which a theoretical framework was utilized, Inmans' seven deadly sins for not reporting ADEs [32,33,35,39,40] ; Knowledge-Attitude-Practice Model (KAP) [29][30][31]34,[41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56] ; and theory of planned behaviour were the most frequently used theories to understand pharmacists' reporting of ADEs. [57] reporting [58] and knowledge [59] of ADEs in two studies.…”

Section: Characteristics Of the Eligible Studiesmentioning

confidence: 99%

Adverse drug event reporting by pharmacists: a systematic literature review

Arabyat

Martinez

Nusair

2019

J Pharm Health Serv Res

View full text Add to dashboard Cite

Background Adverse drug event (ADE) reporting enhances early detection of risks associated with drug use. Pharmacists are uniquely suited to detect and report ADEs, but their contribution is diminished by under‐reporting. Objectives To assess pharmacists' knowledge and perceptions towards ADE reporting and to determine factors that improve or impede reporting using data from published survey articles using PRISMA. Methods A systematic review was conducted to identify published survey articles that assess pharmacists' knowledge of and attitudes towards ADE reporting. PubMed, CINAHL and Web of Science databases were searched. The following information was extracted from eligible articles: demographic factors, sample size, response rate, survey delivery, pharmacists' working setting, barriers and facilitators of ADE reporting. Results Only 68 survey articles were eligible to be included in the review (out of 820). The number of respondents ranges from 10 to 1870, and response rate varied between 10.5% and 100%. Pharmacists working in hospital settings and clinical pharmacists were more likely to report, to have better knowledge, favourable attitudes and familiarity with ADE reporting systems compared to pharmacists working in community settings. The main barrier towards reporting (recorded in >70% of the studies) was lack of confidence/basic knowledge of pharmacovigilance systems/concepts and ADE reporting process. Providing special training and education programmes related to pharmacovigilance concept was the most commonly mentioned factor to enhance reporting. Conclusion To improve ADE reporting by pharmacists, it is recommended to design and integrate educational interventions related to pharmacovigilance within the pharmacy curriculum or continuous education courses.

show abstract

“…Previous studies have reported that although its overall impact was mild, training or educational seminars regarding pharmacovigilance improved the knowledge, attitudes, and practice of pharmacovigilance among various health care providers. 17,18 Laven et al 19 reported that the structured, mandatory training of a pharmacy team and the preparation of a standard operating procedure for a pharmacy or its integration with pharmacy software would lead to the successful integration of pharmacovigilance reporting in daily practice. Kitazawa et al 20 reported that pharmacoepidemiology, including pharmacovigilance, remains an immature field of study and that there are few appropriate textbooks and no teaching experts for pharmacoepidemiology.…”

Section: Discussionmentioning

confidence: 99%

Knowledge, Attitudes, and Practice of Hospital Pharmacists Regarding Pharmacovigilance and Adverse Drug Reaction Reporting in Japan

et al. 2019

View full text Add to dashboard Cite

Background: The importance of pharmacovigilance in Japan is gradually being recognized. However, Japanese pharmacists’ knowledge of and perspectives on pharmacovigilance have been examined only in some areas of Japan. Objective: The objective of this study was to clarify the knowledge, attitudes, and practice regarding pharmacovigilance and adverse drug reaction (ADR) reporting among hospital pharmacists in Japan. Setting: A questionnaire survey among Japanese hospital pharmacists. Method: The questionnaire was distributed to 48 028 pharmacists during a 3-month period between January and March 2017. Main Outcome Measure: The prevalence of hospital pharmacists who understood pharmacovigilance and the ADR reporting system. Results: Of the respondents (response rate; 9.9% = 4760/48 028), 21.9% were <30 years of age, 27.3% were ≥50 years of age, and 46.7% were women. In response to the question “Have you ever heard of the term ‘pharmacovigilance’?,” 12.4%, 33.8%, and 47.4% answered “I understand what it is,” “I have heard of it, but I do not understand what it is,” and “I do not know what it is,” respectively. Pharmacists who understood the term “pharmacovigilance” were also more frequently acquainted with its associated terms and actions. And, 69.7% of respondents wished to acquire more information on pharmacovigilance and 50.9% did not have a personal history of ADR reporting. The most common reason for ADR nonreporting was “It was a well-known adverse drug reaction” (44.5%). Conclusions: Our results suggest that more aggressive promotion of pharmacovigilance and of the ADR reporting system among Japanese pharmacists is needed.

show abstract

Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals

Cited by 11 publications

References 9 publications

Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?

Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?

Adverse drug event reporting by pharmacists: a systematic literature review

Knowledge, Attitudes, and Practice of Hospital Pharmacists Regarding Pharmacovigilance and Adverse Drug Reaction Reporting in Japan

Contact Info

Product

Resources

About